August 2002 Bulletin

Hip, knee focus of first-ever AAOS/industry educational program

Members reap benefits as Academy, industry partner for course

By Carolyn Rogers

An extraordinary educational event is fast approaching. In an effort to keep costs low for attendees while at the same time adding educational value, the Academy is teaming up with major orthopaedic industry and pharmaceutical companies this October to present an unprecedented educational program for orthopaedic surgeons. The four-day course, "Impact of Emerging Technology on Hip and Knee Arthritis and Reconstruction," will take place Oct. 17-20, 2002, in Phoenix, Ariz.

Part of the program time will be devoted to a traditional AAOS course and part of the time has been carved out for industry to offer lectures on topics pertinent to each particular company. Academy sessions will take place on Thursday afternoon, Friday morning and Sunday morning. Industry sessions are scheduled for Friday afternoon and Saturday morning.

"It’s a neat concept," says Charles Clark, MD, course co-chairman along with Courtland G. Lewis, MD. "We’ve sponsored courses with different societies before, but we’ve never partnered with industry."

Academy sessions will focus on cutting-edge technology, Dr. Clark says.

"We’ll get into the latest topics and the newest techniques, so the content will balance well with what industry is offering," he adds. "This should be a win-win for both of us."

Course participants, however, stand to gain the most. In addition to a reduced registration fee, each registrant will take home a $241 value-added bonus package, including:

Participants also will be treated to the beautiful weather and relaxing resort atmosphere of the Pointe Hilton Squaw Peak Resort in Phoenix.

"Firewall" between AAOS and industry sessions

So how is the Academy able to partner with orthopaedic industry while keeping in compliance with Accreditation Council for Continuing Medical Education guidelines?

"We’ve attempted to create a firewall between the Academy program and the industry program," explains James H. Beaty, chair of the CME Courses Committee. "We’re not involved in the planning of the industry program, and we do not accredit their courses. Academy and industry sessions are simply being presented at the same venue."

Six orthopaedic industry and pharmaceutical companies are participating in this program—Aventis Pharmaceuticals, Biomet, Organon Sanofi-Synthelabo, Pharmacia, Wyeth and Zimmer. Each company has provided a $20,000 unrestricted educational grant to the Academy in support of the program. The AAOS will designate a portion of each grant to the Orthopaedic Research and Education Foundation to support orthopaedic research and education.

Course content, faculty

The Academy’s portion of the educational program will focus on emerging technical and procedural developments in hip and knee replacements from cross-linked polyethylene components and alternative bearing surfaces, to minimally invasive, uni-compartmental knee arthroplasty and fixed vs. mobile bearing replacements. With a primary focus on clinical applications, the course will clarify when these new hip and knee procedures and prostheses can be applied and where they belong in patient care.

Upon completion of the AAOS course, participants should be able to:

In addition, Dr. Clark says the program will offer intensive interaction and discussion with faculty on cases and treatments. Participants are encouraged to bring cases with them for discussion with faculty members.

Drs. Clark and Lewis have selected a renowned faculty of orthopaedic surgeons for the Academy’s educational program.They include Daniel J. Berry, MD; Robert E. Booth, Jr., MD; Devon D. Goetz, MD; Arlen D. Hanssen, MD; Michael H. Huo, MD; Richard C. Johnston, MD; Jay R. Lieberman, MD; James A. Rand, MD; Thomas P. Schmalzreid, MD; Richard D. Scott, MD; W. Norman Scott, MD; and Alfred J. Tria, MD.

One-on-one interaction with faculty will be highlighted at a special pre-dinner event on Friday evening. Faculty will be at stations readily available to discuss cases with registrants.

Interactive audience response system

Another unique course feature will be the use of an electronic audience response system to poll attendees on their opinions regarding case treatment options.

"Everyone will have their own voting pad, and results will be immediately tabulated on the screen," explains William P. Barrett, MD, liaison to the CME Courses Committee for the program. "This gives the speaker the opportunity to poll the audience and develop a consensus on the role of new orthopaedic treatment applications.

"Voting on the case studies gives you an unusual opportunity to see how you match up with your peers, " Dr. Barrett says. "It’s anonymous, so people are very honest with their answers. It’s interesting to see how you compare."

Registration fees and CME credit

While the typical AAOS registration fee for a similar program would be $795, the registration fees for this program are:

This registration fee includes three full breakfasts, refreshment breaks, Thursday Chairmen’s Reception, Friday lunch and dinner, and the course Bonus Package. The Friday evening dinner program will feature renowned Taliesin architect Arnold Roy, who will speak about Frank Lloyd Wright’s life and the development of Taliesin West. .

Participants will be asked to designate their participation in the industry instructional sessions at the time of course registration.

To register by phone, contact AAOS customer service at (800) 626-6726, from 8 a.m. to 5 p.m. Central time. To register online, log on to the AAOS Web site at www.aaos.org and select "Medical Education." Click on "CME Course Calendar" and select the Oct. 17-20, 2002 course.

The Academy will designate and award up to 12 hours of continuing medical education Category 1 credit in the AMA’s Physicians’ Recognition Award program for physicians participating in this program. Industry and pharmaceutical companies may designate and award separate Category 1 credit for participation in their program.


Home Previous Page